'Bone metastases' diaporamas de présentation

Role of Bone-Targeted Therapy in the Treatment of Prostate Cancer

Role of Bone-Targeted Therapy in the Treatment of Prostate Cancer. This program is supported by an educational donation from. About These Slides.

1.27k views • 70 slides

Chemotherapy and Radiotherapy in the Palliative Care of Cancer Patients

1.66k views • 67 slides

Secondaries in bone

Secondaries in bone. Content. Introduction Epidemiology Pathogenesis Clinical features Diagnosis Management Medical management Surgical management. Introduction. Introduction.

882 views • 62 slides

Bisphosphonate Related Osteonecrosis of the Jaws

Bisphosphonate Related Osteonecrosis of the Jaws Nik Desai, DMD, MD Division of Oral & Maxillofacial Surgery Department of Plastic Surgery Kaiser Permanente Medical Group Santa Clara, CA 04/28/2010 Objectives Bisphosphonates Clinical applications Drug chemistry Biologic action BRONJ

2.92k views • 61 slides

Best of ASCO GU Session

Best of ASCO GU Session. Sandy Srinivas.MD Stanford University. Outline.

879 views • 59 slides

692 views • 53 slides

739 views • 50 slides

649 views • 50 slides

Current Approaches and New Directions in Treating Bone Metastases from Breast Cancer

Current Approaches and New Directions in Treating Bone Metastases from Breast Cancer. Outline. Biology Symptoms/Imaging Treatment New Directions. Bone Metastases in Breast Cancer. Up to 70% of women with advanced breast cancer may develop bone metastases Early site of spread

468 views • 46 slides

Intern ???

502 views • 39 slides

Manual de prezentare CANTER-Redifos Radioterapia cancerului osos si a metastazelor osoase generalizate

Str. Atomistilor 407, Com.Magurele, jud.Ilfov, C.P. MG-6, cod 077125 tel. (021) 404.23.00; fax (021) 457.44.40; (021) 457.44.32. IFIN-HH.

445 views • 20 slides

Manual de prezentare CANTER-Redifos Radioterapia cancerului osos

Str. Atomistilor 407, Com.Magurele, jud.Ilfov, C.P. MG-6, cod 077125 tel. (021) 404.23.00; fax (021) 457.44.40; (021) 457.44.32. IFIN-HH.

313 views • 20 slides

ROLE OF BONE SCAN VERSUS CONVENTIONAL RADIOLOGY IN THE MANAGEMENT OF CANCER PATIENTS

ROLE OF BONE SCAN VERSUS CONVENTIONAL RADIOLOGY IN THE MANAGEMENT OF CANCER PATIENTS. Dr.Lass G. Hawezi M.B.Ch.B ., C.A.B.M.S., Ortho. Dr.Neyaz H. Ismail M.B.Ch.B ., M. Sc. (N.M.) September 2011. SKELETAL SCINTIGRAPHY.

382 views • 20 slides

AN OVERVIEW OF THE BONE METASTASES PROGRAM

AN OVERVIEW OF THE BONE METASTASES PROGRAM. UNIVERSITY OF CINCINNATI CANCER INSTITUTE LARRY W. PETERS PROGRAM COORDINATOR. CANCER STATISTICS-NATIONAL CANCER INSTITUTE. CANCER STATISTICS 2018 APRIL 27 NATIONAL CANCER INSTITUTE HTTPS://WWW.CANCER.GOV/ABOUTCANCER/UNDERSTANDING/STATISTICS.

445 views • 19 slides

Advances in the Management of Skeletal Related Events/Bone Metastases in Prostate Cancer

Advances in the Management of Skeletal Related Events/Bone Metastases in Prostate Cancer. Robert Dreicer, M.D., M.S., FACP, FASCO Chair Dept of Solid Tumor Oncology Taussig Cancer Institute Cleveland Clinic Professor of Medicine Cleveland Clinic Lerner College of Medicine.

485 views • 16 slides

Prostate Cancer

Imaging of Ra-223 with a small-pixel CdTe detector: potential for improved image quantification for radionuclide dosimetry. James Scuffham 1,2 Silvia Pani 2 , Paul Seller 3 , Paul J Sellin 2 , Matthew C Veale 3 , Matthew D Wilson 3 , Robert J Cernik 4

293 views • 15 slides

Disease Progression in Bone: Overall Population (N = 724)

242 views • 11 slides

Re-irradiation of painful bone metastases

Re-irradiation of painful bone metastases. Warszawski A., Baumgartner M., Baumann R., Bremer M., Karstens J.H., Clinic of Radiotherapy and Special Oncology. Aim:. Evaluation of a second course of radiotherapy (RT) for painful bone metastases with emphasis of overall response,

282 views • 9 slides

Prolia 60mg | Prolia 60mg Injections | denosumab | Apple pharmaceuticals

Prolia 60mg dose belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases.

77 views • 7 slides

Authors: Sunil Verma Date posted: September 28 th , 2009

A Phase III, randomized, double-blind study of denosumab compared with zoledronic acid in the treatment of patients with bone metastases from breast cancer Presented by Dr. Alison Stopeck. Authors: Sunil Verma Date posted: September 28 th , 2009. Arm A: Denosumab 120mg sc + Placebo IV

196 views • 5 slides